Medical Research
(H11)
IRS Verified
DX Registered
990 on File
LUPUS RESEARCH ALLIANCE INC
Financial strength (30%)
69/100
Reliability (20%)
55/100
Effectiveness (25%)
88/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
Born from the merger of three organizations with a common belief in the potential for science to overcome lupus, the Lupus Research Alliance is at the forefront of driving innovative research that can make a difference for people living with the prototypical autoimmune disease. With that shared conviction, the Board of Directors promises to cover all administrative and operating costs of the organization, ensuring that 100% of all donations go directly to funding research programs in order to realize our vision of a world free of lupus.
Financial Overview — FY 2024
$18.6M
Total Revenue
$38.2M
Total Expenses
$55.7M
Net Assets
72
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
78.6%
Fundraising Efficiency
607.2%
Operating Reserve
17.51x
Liability-to-Asset
40.3%
Revenue Diversification
60.2%
Executive Compensation
$2.5M
Compared with Peers
FY 2024
Compared with 98 similar organizations
(United States, Medical Research, $10M–$100M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
78.6% | 82.0% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
10.4% | 12.7% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
11.0% | 0.7% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
607.2% | 693.4% |
P10P90
|
Above median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
17.5 mo | 14.5 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
40.3% | 21.3% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
60.2% | 90.8% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
-63.5% | 9.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
7.8% | 7.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-105.7% | -1.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $18.6M | $38.2M | $55.7M | 78.6% | 72 |
| 2023 | $50.9M | $35.4M | $75.3M | 79.7% | 73 |
| 2022 | $22.7M | $32.4M | $63.5M | 81.2% | 63 |
| 2021 | $23.8M | $26.8M | $69.5M | 80.8% | 59 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.